Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients

Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients

<p>Abstract</p> <p>Background</p> <p>No study has compared the long-term prognoses of hepatitis C patients with hepatitis C virus (HCV) antibody-negative individuals and investigated the effects of interferon (IFN) treatment. To clarify the long-term prognosis of HCV-po...

Full description

Bibliographic Details
Main Authors:	Yamasaki Kazumi, Tomohiro Mayumi, Nagao Yumiko, Sata Michio, Shimoda Toshiaki, Hirase Kazuhiro, Shirahama Satoshi
Format:	Article
Language:	English
Published:	BMC 2012-10-01
Series:	BMC Gastroenterology
Subjects:	Hepatitis C virus Hepatocellular carcinoma Prospective cohort study Interferon Life expectancy
Online Access:	http://www.biomedcentral.com/1471-230X/12/139

Similar Items

Analysis of the factors motivating HCV-infected patients to accept interferon therapy
by: Nagao Yumiko, et al.
Published: (2012-08-01)

Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study
by: Nagao Yumiko, et al.
Published: (2012-11-01)

Hepatocellular Carcinoma 11 and a Half Years after the Resolution of Chronic Hepatitis C Virus Infection Successfully Treated with Interferon
by: Naoki Hotta, et al.
Published: (2009-07-01)

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon
by: Sandro da Costa Ferreira, et al.

Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin
by: Chia-Min Wu, et al.
Published: (2021-03-01)

Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection Neumonitis intersticial secundaria a tratamiento con interferón pegilado
by: J. Torres Macho, et al.
Published: (2010-10-01)

Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report
by: Kenji Misaka, et al.
Published: (2016-10-01)

Pegylated Interferons and Their Use in Clinical Practice
by: Alpay AZAP, et al.
Published: (2003-12-01)

Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Timokratis Karamitros, et al.
Published: (2018-04-01)

Hepatitis C-Related Cirrhosis with Sustained Prevention of Hepatocellular Carcinoma Recurrence by Long-Term Administration of Super-Low-Dose Peginterferon-Alpha 2b
by: Satoshi Mamori, et al.
Published: (2011-01-01)

Tratamiento de la hepatitis viral aguda c con interferón alfa 2b recombinante: Ensayo clínico
by: Enrique Arús Soler, et al.
Published: (2000-03-01)

The use of interferon in medicine
by: Waldemar Pluta, et al.
Published: (2020-06-01)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
by: Ioannis Varbobitis, et al.
Published: (2016-09-01)

Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy
by: Hu CC, et al.
Published: (2018-04-01)

Effect of interferons on expression of adenosine deaminase acting on RNA 1 and hepatitis B virus replication in human hepatocellular carcinoma cells in vitro
by: LI Yimin, et al.
Published: (2019-07-01)

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
by: Aline Gonzalez Vigani, et al.

A case of autoimmune hepatitis following pegylated interferon treatment of chronic hepatitis delta
by: Feruze Enc, et al.
Published: (2020-08-01)

Tratamiento de hepatitis C en la insuficiencia renal crónica terminal en hemodiálisis con Interferón 2 b y ribavirina: A case report Treatment of hepatitis C in end-stage chronic renal failure in hemodialysis with Interferon 2 b and ribavirine
by: Yanet Parodis López, et al.
Published: (2005-08-01)

Virus B e interferón
by: Gerardo Avendaño-Alvarado
Published: (2008-11-01)

Tolerance and Efficacy of Interferon-alpha in Hemodialysis Patients in Tripoli
by: Buargub Mahdia, et al.
Published: (2006-01-01)

Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy
by: Roberta D'Ambrosio, et al.
Published: (2015-08-01)

Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
by: Hawraa Shwaylia, et al.
Published: (2021-06-01)

Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study
by: Oh Jin-Kyoung, et al.
Published: (2012-10-01)

Unusual course of interferon-related retinopathy in chronic hepatitis C
by: Gaurav Mathur, et al.
Published: (2016-01-01)

Hepatitis B, interferon, and acne fulminans in a young girl
by: Sandeep Arora, et al.
Published: (2016-01-01)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
by: Pil Soo Sung, et al.
Published: (2018-09-01)

Evaluation of Response to Interferon Therapy in Chronic Hepatitis B and Chronic Hepatitis C Patients
by: Hakan LEBLEBİCİOĞLU, et al.
Published: (2001-09-01)

Dental problems delaying the initiation of interferon therapy for HCV-infected patients
by: Nagao Yumiko, et al.
Published: (2010-08-01)

Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma
by: Prajina Rahul, et al.
Published: (2016-01-01)

Interferon-ribavirin therapy for chronic hepatitis C: Efficacy in Saudi patients
by: Sandokji Abdulkareem, et al.
Published: (2003-01-01)

INTERFERON-FREE THERAPY FOR HEPATITIS C IN PAKISTAN
by: Dure Nayab, et al.
Published: (2017-03-01)

Interferon alpha, gamma, and lambda 2: are they possible culprits in the association between psoriasis and hepatitis C virus?
by: Randa Youssef, et al.
Published: (2019-01-01)

Epidemiological characteristics and prognosis of hepatocellular carcinoma: A single-center observational real-world cohort study of 1302 cases
by: HE Yajing, et al.
Published: (2019-05-01)

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Edmundo P.A. Lopes, et al.

Therapy with interferon-a plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Lopes Edmundo P.A., et al.
Published: (2003-01-01)

Concurrent autoimmune hepatitis and grave′s disease in Hepatitis C during pegylated Interferon α-2a and ribavirin therapy
by: Guru V Trikudanathan, et al.
Published: (2011-01-01)

Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy
by: Giuliano Ramadori, et al.
Published: (2018-03-01)

Expert consensus on clinical management of adverse reactions in interferon-α therapy for chronic viral hepatitis
by: Expert Committee on Clinical Management of Adverse Reactions in Interferon-α Therapy for Chronic Viral Hepatitis
Published: (2014-11-01)

Effect of interferon treatment on hearing of patients with chronic Hepatitis C
by: Abdulrahman Hagr, et al.
Published: (2011-01-01)

Individualized treatment with pegylated interferon-α for chronic hepatitis B
by: WAN Mobin
Published: (2018-05-01)